[Supplemental therapy in gynecological neoplasms].
D002822:Choriocarcinoma / Q000188:drug therapy; D003037:Cobalt Radioisotopes; D004317:Doxorubicin / Q000627:therapeutic use*; D004361:Drug Tolerance; D005260:Female; D005833:Genital Neoplasms, Female / Q000628:therapy*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007167:Immunotherapy / Q000592:standards; D008727:Methotrexate / Q000627:therapeutic use; D010347:Patient Care Planning; D011247:Pregnancy; D011878:Radiotherapy / Q000592:standards; D012509:Sarcoma / Q000188:drug therapy; D014625:Vaginal Neoplasms / Q000532:radiotherapy; D014846:Vulvar Neoplasms / Q000532:radiotherapy / Q000601:surgery
D003037:Cobalt Radioisotopes; D007093:Imidazoles; D004317:Doxorubicin; D008727:Methotrexate
Zusatztherapie gynäkologischer Karzinome.